Selective Nerve Activation for Brown Adipose Tissue Stimulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating obesity, including surgical procedures and pharmaceutical approaches, are limited in effectiveness and often come with undesirable side effects, and there is a need for non-invasive techniques to activate brown adipose tissue (BAT) to increase energy expenditure and metabolic rate.

Innovation Solution

The use of electrical energy to selectively activate sympathetic nerves in BAT without activating parasympathetic or sensory nerves, using devices that deliver electrical signals with specific current and pulse width parameters to stimulate thermogenesis and weight loss.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If surgical procedures are used to treat obesity, then weight loss can be achieved, but postoperative pain, wound infection risk, and recovery time increase

Engineering Contradiction:
Improveweight loss effectivenessVSAvoidpostoperative pain and infection risk
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces mechanical surgical intervention with electrical field stimulation to activate brown adipose tissue. Instead of physically altering the body through surgery, the invention uses non-invasive electrical signals to stimulate sympathetic nerves and activate BAT, thereby achieving weight loss without surgical trauma, pain, or infection risk.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces brown adipose tissue as an intermediary mechanism to achieve weight loss. Electrical stimulation activates BAT, which then metabolizes fat through thermogenesis. This intermediary biological system mediates the weight loss effect without requiring direct surgical intervention on the gastrointestinal tract or other organs.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If electrical signals are delivered to activate BAT, then selective nerve activation can be achieved, but precise control of current and pulse width parameters is required

Engineering Contradiction:
Improveselective nerve activationVSAvoidparameter control requirements
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent utilizes specific electrical parameter ranges (current: 1-1000 μA, pulse width: 10-1000 μs) to achieve selective activation of sympathetic nerves in BAT. By optimizing these parameters, the invention distinguishes between different nerve types based on their electrical thresholds, enabling selective stimulation without activating parasympathetic or sensory nerves.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replicates the natural sympathetic nervous system activation pattern that occurs during cold exposure. The electrical signals mimic physiological conditions that naturally activate BAT, thereby achieving selective nerve activation through biologically relevant parameter patterns rather than arbitrary electrical stimulation.

Inventive Principle:
Principle #26Copying

3Ease of operation

If transcutaneous electrical delivery is used, then non-invasive treatment can be achieved, but signal penetration depth and tissue impedance affect delivery efficiency

Engineering Contradiction:
Improvenon-invasive treatmentVSAvoidsignal delivery efficiency
Core Design Contradiction:
Ease of operationVSUse of energy by moving object

Solution Approach 1:

The patent employs pulsed electrical delivery rather than continuous signals. The periodic pulsing allows tissue impedance to reset between pulses, improving signal penetration efficiency. The intermittent nature of pulsed delivery also reduces overall energy consumption compared to continuous stimulation while maintaining effective BAT activation during pulse periods.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The patent uses adjustable electrical parameters that can be dynamically optimized based on individual patient characteristics, tissue impedance measurements, and treatment response. This dynamic adaptation allows the system to overcome variable tissue impedance barriers and achieve efficient signal penetration without requiring excessive energy input.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for increased energy expenditure and weight loss without surgical intervention or pharmaceuticals, improving metabolic outcomes and reducing comorbidities associated with obesity, such as Type II diabetes and high blood pressure.

Implementation Method 1

activating the device to transcutaneously deliver an electrical signal to the patient so as to activate a first nerve type in the BAT

Methodology Applied
Scientific EffectElectrical stimulation: Electrical Impedance Tomography

Data Source

PatentUS11679252B2Methods and devices for activating brown adipose tissue using electrical energy
Publication Date: 2023.06.20 CILAG GMBH INTERNATIONAL
  • US11679252B2 patent drawing
  • US11679252B2 patent drawing
  • US11679252B2 patent drawing

AI summary

Methods and devices are provided for activating brown adipose tissue (BAT) using electrical energy. In general, the methods and devices can facilitate activation of BAT to increase thermogenesis. The BAT can be activated by applying an electrical signal thereto that can be configured to target sympathetic nerves that can directly innervate the BAT. The electrical signal can be configured to target the sympathetic nerves using fiber diameter selectivity. In other words, the electrical signal can be configured to activate nerve fibers having a first diameter without activating nerve fibers having diameters different than the first diameter. Sympathetic nerves include postganglionic unmyelinated, small diameter fibers, while parasympathetic nerves that can directly innervate BAT include preganglionic myelinated, larger diameter fibers. The electrical signal can be configured to target and activate the postganglionic unmyelinated, small diameter fibers without activating the preganglionic myelinated, larger diameter fibers.